Studies reported that Nrf2 knockdown in combination with cisplatin, paclitaxel, doxorubicin, or 5-FU reduces GSH levels and promotes cancer cell apoptosis by modulating mitochondrial BAX 108. This evidence concerns the gene NFE2L2 and cancer.